Global Animal Antibiotics and Antimicrobials Market 2017-2022 - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others
Global Animal Antibiotics and Antimicrobials Market 2017-2022 - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others
DUBLIN, March 22, 2018 /PRNewswire/ --
The "Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
Global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 - 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.
Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
-- Global Animal Antibiotics and Antimicrobials Market, By Value
-- By Product Type - Penicillins, Fluoroguinolones, Aminoglycosides,
Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides,
Cephalosporins and Others)
-- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections,
Others
-- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections,
Others
-- By Type of Animals - Farm Animals, Companion Animals
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Antibiotics & Antimicrobials Product Outlook
5. Global Antibiotics & Antimicrobials Market: Growth and Forecast
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections , By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)
6. North America Antibiotics & Antimicrobials Market: Growth and Forecast
7. Europe Antibiotics & Antimicrobials Market: Growth and Forecast
8. Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
9. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases
10. Market Restraints
11. Consolidation of the Industry
12. Porter's Five Forces Analysis - Heart Valve Devices Market
13. SWOT Analysis -Heart Valve Devices Market
14. Policy and Regulations
15. Company Profiles
-- Bayer AG
-- Boehringer Ingelheim GmbH
-- Ceva Sante Animale
-- Dechra Pharmaceuticals PLC
-- Eli Lilly and Company
-- Merck & Co. Inc.
-- Phibro Animal Health Corporation
-- Vetoquinol S.A.
-- Virbac
-- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/research/zx68m9/global_animal?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
